Results 131 to 140 of about 1,627,676 (310)

Educational programme for patients with type 2 diabetes at community health centres : what is the evidence? [PDF]

open access: yes, 2007
With increasing prevalence of diabetes mellitus type 2, more patients will require intensive management with diet, exercise, oral hypoglycaemic medication, and insulin replacement therapy in the primary care setting.
Cilia, Saviour
core  

Caracterización sociodemográfica y temporal de la diabetes mellitus tipo 2 Socio-demographic and temporal characterization of type-2 diabetes mellitus

open access: yesRevista de Ciencias Médicas de Pinar del Río, 2012
Introducción: la diabetes mellitus tipo 2 constituye un problema de salud que afecta a la humanidad, por lo que se hace necesaria su investigación en aspectos sociodemográficos y temporales.
Max Ramiro Ochoa Ortega   +4 more
doaj  

Metabolic and Microvascular Risk Factors Associated With Brain Health in Type 1 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We examined relationships between metabolic factors, microvascular complications, and brain health in adults with type 1 diabetes. Fifty‐one adults were assessed for metabolic risk factors, microvascular complications, and cognitive function, with a subset completing brain MRI.
Jihyun Park   +7 more
wiley   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit   +11 more
wiley   +1 more source

Session 14: A Closer Look at Type 2 Diabetes (Handout) [PDF]

open access: yes
Session 14: A Closer Look at Type 2 Diabetes (Handout)National Diabetes Prevention Program ...

core  

Interaction of Intraprocedural Antiplatelets and Intravenous Thrombolysis in Acute Intracranial Stenting: RESISTANT Registry Subanalysis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction/Objective Acute intracranial stenting during endovascular thrombectomy (EVT) for ischemic stroke requires intraprocedural antiplatelet therapy (APT) to maintain patency. However, the hemorrhagic risk of combining APT with intravenous thrombolysis (IVT) remains uncertain.
Aaron Rodriguez‐Calienes   +75 more
wiley   +1 more source

National Diabetes Prevention Program : working together to prevent type 2 diabetes [Spanish] [PDF]

open access: yes
National Diabetes Prevention Program : working together to prevent type 2 diabetes [Spanish]La creciente amenaza de la prediabetes: 84.1 MILLONES de adultos tienen prediabetes.Averigu\u308e co\u301mo trabajar con el Programa Nacional de Prevencio\u301n ...

core  

Bi‐ and Mono‐Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective RFC1 biallelic repeat expansion is increasingly recognized as a cause of chronic idiopathic axonal polyneuropathy (CIAP), but it remains challenging to know who to test. This study aims to determine the prevalence of biallelic and monoallelic RFC1 expansions and their corresponding neuropathy phenotypes in CIAP patients and identify ...
Amro M. Stino   +25 more
wiley   +1 more source

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova   +9 more
wiley   +1 more source

Peroxisome Proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes [PDF]

open access: yes, 2005
Dysregulation of fatty acid metabolism is important in the pathogenesis of type 2 diabetes. Peroxisome proliferator-activated receptor (PPAR) is a master regulator of fatty acid catabolism, and PPAR activators delay the onset of type 2 diabetes.
Ireland, H.   +7 more
core  

Home - About - Disclaimer - Privacy